Reata Pharma (RETA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RETA | AMGN | GILD | BIIB | CELG |
| Company | Reata Pharma | Amgen Inc | Gilead Sciences Inc | Biogen Inc | Celgene Corp |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 172.34 | 265.72 | 65.50 | 201.22 | 108.01 |
| High | 172.46 | 271.68 | 66.35 | 210.83 | 108.59 |
| Low | 172.32 | 265.72 | 64.63 | 199.10 | 107.27 |
| Last | 172.36 | 269.98 | 65.42 | 208.90 | 108.24 |
| Change | +0.04 | +0.60 | +0.15 | +6.44 | +0.11 |
| % Change | +0.02% | +0.22% | +0.23% | +3.18% | +0.10% |
| Volume | 1,988,500 | 2,436,900 | 12,380,800 | 1,893,800 | 191,230,496 |
| 20-Day Average Volume | 810,510 | 2,156,940 | 7,062,310 | 1,280,090 | 16,188,930 |
| Previous Close | 172.32 | 269.38 | 65.27 | 202.46 | 108.13 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | No |
| Technicals | |||||
| 20-Day Moving Average | 170.84 | 269.99 | 68.29 | 201.13 | 108.17 |
| 20-Day Raw Stochastic | 97.36% | 40.03% | 9.20% | 74.13% | 63.25% |
| 20-Day Relative Strength | 81.56% | 45.47% | 29.21% | 49.77% | 64.69% |
| Weighted Alpha | +177.60 | +9.45 | -23.49 | -31.63 | +46.30 |
| Today's Opinion | 100% Buy | 72% Sell | 100% Sell | 88% Sell | 100% Buy |
| Previous Opinion | 100% Buy | 72% Sell | 100% Sell | 88% Sell | 100% Buy |
| Last Month's Opinion | 100% Buy | 40% Buy | 88% Sell | 100% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.18% since 09/18/23 | +0.39% since 04/19/24 | -2.01% since 04/19/24 | +7.47% since 04/19/24 | -1.97% since 11/13/19 |
| Low | 171.96 on 09/19/23 | 265.72 on 04/26/24 | 64.63 on 04/26/24 | 192.75 on 04/23/24 | 107.27 on 11/20/19 |
| High | 172.46 on 09/25/23 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 210.83 on 04/26/24 | 110.53 on 11/14/19 |
| 1-Month | |||||
| %Chg | +1.99% since 08/25/23 | -4.18% since 03/26/24 | -9.65% since 03/26/24 | -1.47% since 03/26/24 | +5.14% since 10/18/19 |
| Low | 168.67 on 09/05/23 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 189.44 on 04/19/24 | 102.40 on 10/21/19 |
| High | 172.46 on 09/25/23 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 217.57 on 03/28/24 | 110.70 on 11/13/19 |
| 3-Month | |||||
| %Chg | +83.77% since 06/23/23 | -13.40% since 01/26/24 | -17.73% since 01/26/24 | -14.67% since 01/26/24 | +13.63% since 08/20/19 |
| Low | 88.80 on 06/27/23 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 189.44 on 04/19/24 | 93.41 on 08/23/19 |
| High | 172.46 on 09/25/23 | 329.72 on 02/05/24 | 80.00 on 01/29/24 | 251.99 on 01/31/24 | 110.70 on 11/13/19 |
| 6-Month | |||||
| %Chg | +101.14% since 03/24/23 | +0.10% since 10/26/23 | -16.66% since 10/26/23 | -13.35% since 10/26/23 | +14.14% since 05/20/19 |
| Low | 76.54 on 05/10/23 | 249.70 on 10/31/23 | 64.63 on 04/26/24 | 189.44 on 04/19/24 | 89.08 on 07/23/19 |
| High | 172.46 on 09/25/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 268.30 on 01/03/24 | 110.70 on 11/13/19 |
| Key Statistics | |||||
| Market Capitalization, $K | 6,575,535 | 144,488,960 | 81,266,176 | 29,429,788 | 77,035,920 |
| Shares Outstanding, K | 38,150 | 536,376 | 1,245,077 | 145,361 | 711,714 |
| Annual Sales | 2,220,000 | 28,190,000,000 | 27,116,000,000 | 9,835,600,000 | 15,281,000,000 |
| Annual Net Income | -311,900,000 | 6,717,000,000 | 5,665,000,000 | 1,161,100,000 | 4,046,000,000 |
| Last Quarter Sales | 22,750,000 | 8,196,000,000 | 7,114,000,000 | 2,386,300,000 | 4,520,000,000 |
| Last Quarter Net Income | 193,000,000 | 767,000,000 | 1,429,000,000 | 249,700,000 | 1,691,000,000 |
| 60-Month Beta | 1.42 | 0.58 | 0.19 | -0.02 | 1.41 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.32 on 08/08/23 | 4.71 on 02/06/24 | -1.32 on 04/25/24 | 3.67 on 04/24/24 | 2.99 on 10/31/19 |
| Latest Earnings Date | 11/14/23 | 05/02/24 | 04/25/24 | 04/24/24 | 10/31/19 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.64 | 9.98 | 13.47 | 10.99 |